Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 75-85

  Clifford, Rachel L ^a   Singer, Cherie A ^b   John, Alison E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway smooth muscle; Asthma; Epigenetics; Inflammation; MicroRNA; Remodeling

Indexed keywords

DNA; HISTONE; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 206; MICRORNA 26A; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CELL FUNCTION; CELL PROLIFERATION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; INNERVATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SMOKING; SMOOTH MUSCLE FIBER;

AIRWAY REMODELING; ANIMALS; CELL PROLIFERATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; INFLAMMATION; MICRORNAS; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84873189092     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.07.002     Document Type: Article

References (109)

1. Berger S.L., Kouzarides T., Shiekhattar R., Shilatifard A. An operational definition of epigenetics. Genes Dev 2009, 23:781-783.
2. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009, 10:295-304.
3. Walser J.C., Ponger L., Furano A.V. CpG dinucleotides and the mutation rate of non-CpG DNA. Genome Res 2008, 18:1403-1414.
4. Medvedeva Y.A., Fridman M.V., Oparina N.J., Malko D.B., Ermakova E.O., Kulakovskiy I.V., et al. Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genom 2010, 11:48.
5. Seidl C.I., Stricker S.H., Barlow D.P. The imprinted air ncRNA is an atypical RNAPII transcript that evades splicing and escapes nuclear export. EMBO J 2006, 25:3565-3575.
6. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev 2011, 25:1010-1022.
7. Lorincz M.C., Dickerson D.R., Schmitt M., Groudine M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 2004, 11:1068-1075.
8. Cheng X., Blumenthal R.M. Mammalian DNA methyltransferases: a structural perspective. Structure 2008, 16:341-350.
9. Goll M.G., Kirpekar F., Maggert K.A., Yoder J.A., Hsieh C.L., Zhang X., et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006, 311:395-398.
10. Rai K., Chidester S., Zavala C.V., Manos E.J., James S.R., Karpf A.R., et al. Dnmt2 functions in the cytoplasm to promote liver, brain, and retina development in zebrafish. Genes Dev 2007, 21:261-266.
11. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
12. Nightingale K.P., O'Neill L.P., Turner B.M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev 2006, 16:125-136.
13. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
14. Han J., Lee Y., Yeom K.H., Nam J.W., Heo I., Rhee J.K., et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006, 125:887-901.
15. Taft R.J., Pang K.C., Mercer T.R., Dinger M., Mattick J.S. Non-coding RNAs: regulators of disease. J Pathol 2010, 220:126-139.
16. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862.
17. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
18. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157.
19. Canning B.J. Reflex regulation of airway smooth muscle tone. J Appl Physiol 2006, 101:971-985.
20. Bohnsack M.T., Czaplinski K., Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10:185-191.
21. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436:740-744.
22. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
23. Forman J.J., Legesse-Miller A., Coller H.A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A 2008, 105:14879-14884.
24. Albinsson S., Skoura A., Yu J., DiLorenzo A., Fernandez-Hernando C., Offermanns S., et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS One 2011, 6:e18869.
25. Park C., Yan W., Ward S.M., Hwang S.J., Wu Q., Hatton W.J., et al. MicroRNAs dynamically remodel gastrointestinal smooth muscle cells. PLoS One 2011, 6:e18628.
26. Dekkers B.G., Bos I.S., Zaagsma J., Meurs H. Functional consequences of human airway smooth muscle phenotype plasticity. Br J Pharmacol 2011.
27. Alexander M.R., Owens G.K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012, 74:13-40.
28. Joshi S.R., McLendon J.M., Comer B.S., Gerthoffer W.T. MicroRNAs-control of essential genes: implications for pulmonary vascular disease. Pulm Circ 2011, 1:357-364.
29. Hirst S.J., Twort C.H., Lee T.H. Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol 2000, 23:335-344.
30. Halayko A.J., Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003, 137:209-222.
31. John A.E., Zhu Y.M., Brightling C.E., Pang L., Knox A.J. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J Immunol 2009, 183:4682-4692.
32. Chan V., Burgess J.K., Ratoff J.C., O'Connor B.J., Greenough A., Lee T.H., et al. Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2006, 174:379-385.
33. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171:1103-1108.
34. John A.E., Clifford R.L., Brightling C.E., Knox A.J. Basal hypersecretion of CXCL8 in asthmatic human airway smooth muscle cells is associated with increased binding of histone acetyltransferases to the CXCL8 promoter and acetylation of histone H3. Am J Respir Crit Care Med 2010, A2145. New Orleans: American Thoracic Society.
35. Keslacy S., Tliba O., Baidouri H., Amrani Y. Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol 2007, 71:609-618.
36. Nie M., Knox A.J., Pang L. beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 2005, 175:478-486.
37. Joubert P., Lajoie-Kadoch S., Labonte I., Gounni A.S., Maghni K., Wellemans V., et al. CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 2005, 175:2702-2708.
38. Uhm T.G., Lee S.K., Kim B.S., Kang J.H., Park C.S., Rhim T.Y., et al. CpG methylation at GATA elements in the regulatory region of CCR3 Positively correlates with CCR3 transcription. Exp Mol Med 2012.
39. Clarke D.L., Clifford R.L., Jindarat S., Proud D., Pang L., Belvisi M., et al. TNFalpha and IFNgamma synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-kappaB, and the transcriptional coactivator CREB-binding protein. J Biol Chem 2010, 285:29101-29110.
40. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
41. McDonald O.G., Wamhoff B.R., Hoofnagle M.H., Owens G.K. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 2006, 116:36-48.
42. Sambucetti L.C., Fischer D.D., Zabludoff S., Kwon P.O., Chamberlin H., Trogani N., et al. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 1999, 274:34940-34947.
43. Okamoto H., Fujioka Y., Takahashi A., Takahashi T., Taniguchi T., Ishikawa Y., et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). J Atheroscler Thromb 2006, 13:183-191.
44. Araujo B.B., Dolhnikoff M., Silva L.F., Elliot J., Lindeman J.H., Ferreira D.S., et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J 2008, 32:61-69.
45. Johnson P.R., Burgess J.K., Underwood P.A., Au W., Poniris M.H., Tamm M., et al. Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 2004, 113:690-696.
46. Pons D., de Vries F.R., van den Elsen P.J., Heijmans B.T., Quax P.H., Jukema J.W. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. Eur Heart J 2009, 30:266-277.
47. Clifford R.L., John A.E., Brightling C.E., Knox A.J. Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma. J Immunol 2012.
48. McDonald D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001, 164:S39-S45.
49. Simcock D.E., Kanabar V., Clarke G.W., Mahn K., Karner C., O'Connor B.J., et al. Induction of angiogenesis by airway smooth muscle from patients with asthma. Am J Respir Crit Care Med 2008, 178:460-468.
50. Cacoub P., Dorent R., Nataf P., Carayon A., Riquet M., Noe E., et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997, 33:196-200.
51. Giaid A., Yanagisawa M., Langleben D., Michel R.P., Levy R., Shennib H., et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993, 328:1732-1739.
52. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006, 99:675-691.
53. Van Rheen Z., Fattman C., Domarski S., Majka S., Klemm D., Stenmark K.R., et al. Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 2011, 44:500-508.
54. Nozik-Grayck E., Suliman H.B., Majka S., Albietz J., Van Rheen Z., Roush K., et al. Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2008, 295:L422-L430.
55. Kamezaki F., Tasaki H., Yamashita K., Tsutsui M., Koide S., Nakata S., et al. Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 2008, 177:219-226.
56. Zelko I.N., Stepp M.W., Vorst A.L., Folz R.J. Histone acetylation regulates the cell-specific and interferon-gamma-inducible expression of extracellular superoxide dismutase in human pulmonary arteries. Am J Respir Cell Mol Biol 2011, 45:953-961.
57. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588. [Epub 2007 May 3].
58. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
59. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009, 23:2166-2178.
60. Kuhn A.R., Schlauch K., Lao R., Halayko A.J., Gerthoffer W.T., Singer C.A. MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol 2010, 42:506-513.
61. Williams A.E., Larner-Svensson H., Perry M.M., Campbell G.A., Herrick S.E., Adcock I.M., et al. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS ONE 2009, 4:e5889.
62. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658. [Epub 2009 Apr 30].
63. Sun S.G., Zheng B., Han M., Fang X.M., Li H.X., Miao S.B., et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011, 12:56-62. [Epub 2010 Nov 26].
64. Xie C., Huang H., Sun X., Guo Y., Hamblin M., Ritchie R.P., et al. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 2011, 20:205-210. [Epub 2010 Oct 18].
65. Munguia R., Kuhn A.R., Singer C.A. Expression of microRNA-25 inhibits airway smooth muscle cell proliferation. Am J Respir Crit Care Med 2010, A2011. New Orleans, LA: American Thoracic Society.
66. Garbacki N., Di Valentin E., Huynh-Thu V.A., Geurts P., Irrthum A., Crahay C., et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS ONE 2011, 6:e16509.
67. 2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice. Respir Res 2005, 6:4.
68. Schaafsma D., Gosens R., Zaagsma J., Halayko A.J., Meurs H. Rho kinase inhibitors: a novel therapeutical intervention in asthma?. Eur J Pharmacol 2008, 585:398-406. [Epub 2008 Mar 18].
69. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618. [Epub 2007 Apr 29].
70. Chiba Y., Tanabe M., Goto K., Sakai H., Misawa M. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care Med 2009, 180:713-719.
71. Undem B.J., Kajekar R., Hunter D.D., Myers A.C. Neural integration and allergic disease. J Allergy Clin Immunol 2000, 106:S213-S220.
72. Kerzel S., Path G., Nockher W.A., Quarcoo D., Raap U., Groneberg D.A., et al. Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol Biol 2003, 28:170-178.
73. Radzikinas K., Aven L., Jiang Z., Tran T., Paez-Cortez J., Boppidi K., et al. A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle. J Neurosci 2011, 31:15407-15415.
74. Kim H.K., Lee Y.S., Sivaprasad U., Malhotra A., Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006, 174:677-687.
75. Ebina M., Takahashi T., Chiba T., Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993, 148:720-726.
76. Mohamed J.S., Lopez M.A., Boriek A.M. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem 2010, 285:29336-29347.
77. Bentley J.K., Deng H., Linn M.J., Lei J., Dokshin G.A., Fingar D.C., et al. Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3(beta) phosphorylation in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol 2009, 296:L176-L184. [Epub 2008 Nov 14].
78. Mohamed J.S., Hajira A., Li Z., Paulin D., Boriek A.M. Desmin regulates airway smooth muscle hypertrophy through early growth-responsive protein-1 and microRNA-26a. J Biol Chem 2011, 286:43394-43404. [Epub 2011 Sep 7].
79. Larner-Svensson H.M., Williams A.E., Tsitsiou E., Perry M.M., Jiang X., Chung K.F., et al. Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respir Res 2010, 11:68.
80. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009, 16:1590-1598. [Epub 2009 Oct 9].
81. Collison A., Herbert C., Siegle J.S., Mattes J., Foster P.S., Kumar R.K. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med 2011, 11:29.
82. Eder W., Ege M.J., von Mutius E. The asthma epidemic. N Engl J Med 2006, 355:2226-2235.
83. Durham A.L., Wiegman C., Adcock I.M. Epigenetics of asthma. Biochim Biophys Acta 2011, 1810:1103-1109.
84. Lovinsky-Desir S., Miller R.L. Epigenetics, asthma, and allergic diseases: a review of the latest advancements. Curr Allergy Asthma Rep 2012, 12:211-220.
85. Whitrow M.J., Moore V.M., Rumbold A.R., Davies M.J. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol 2009, 170:1486-1493.
86. Haberg S.E., London S.J., Stigum H., Nafstad P., Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009, 94:180-184.
87. Hollingsworth J.W., Maruoka S., Boon K., Garantziotis S., Li Z., Tomfohr J., et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008, 118:3462-3469.
88. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005, 11:50-55. [Epub 2004 Dec 26].
89. Hillemacher T., Frieling H., Moskau S., Muschler M.A., Semmler A., Kornhuber J., et al. Global DNA methylation is influenced by smoking behaviour. Eur Neuropsychopharmacol 2008, 18:295-298.
90. Breton C.V., Byun H.M., Wenten M., Pan F., Yang A., Gilliland F.D. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009, 180:462-467.
91. Franco R., Schoneveld O., Georgakilas A.G., Panayiotidis M.I. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008, 266:6-11.
92. Su R.C., Becker A.B., Kozyrskyj A.L., Hayglass K.T. Altered epigenetic regulation and increasing severity of bronchial hyperresponsiveness in atopic asthmatic children. J Allergy Clin Immunol 2009, 124:1116-1118.
93. Ito K., Lim S., Caramori G., Chung K.F., Barnes P.J., Adcock I.M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001, 15:1110-1112.
94. Ito K., Caramori G., Lim S., Oates T., Chung K.F., Barnes P.J., et al. Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 2002, 166:392-396.
95. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007, 104:15805-15810. [Epub 2007 Sep 21].
96. Mattes J., Collison A., Plank M., Phipps S., Foster P.S. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 2009, 20:20.
97. Kumar M., Ahmad T., Sharma A., Mabalirajan U., Kulshreshtha A., Agrawal A., et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol 2011, 128:1077-1085. [e1-10, Epub 2011 May 25].
98. Lu T.X., Munitz A., Rothenberg M.E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009, 182:4994-5002.
99. Perry M.M., Moschos S.A., Williams A.E., Shepherd N.J., Larner-Svensson H.M., Lindsay M.A. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008, 180:5689-5698.
100. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
101. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human MicroRNA targets. PLoS Biol 2004, 2:e363. [Epub 2004 Oct 5].
102. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. [Epub 2005 Apr 3].
103. Nicolae D., Cox N.J., Lester L.A., Schneider D., Tan Z., Billstrand C., et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005, 76:349-357. [Epub 2004 Dec 20].
104. Castelli E.C., Moreau P., Oya e Chiromatzo A., Mendes-Junior C.T., Veiga-Castelli L.C., Yaghi L., et al. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009, 70:1020-1025.
105. Hamm C.A., Costa F.F. The impact of epigenomics on future drug design and new therapies. Drug Discov Today 2011, 16:626-635.
106. Callinan P.A., Feinberg A.P. The emerging science of epigenomics. Hum Mol Genet 2006, 15(1):R95-R101.
107. Roccaro A.M., Sacco A., Jia X., Azab A.K., Maiso P., Ngo H.T., et al. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 2010, 116:1506-1514. [Epub 2010 Jun 2].
108. Montgomery R.L., Hullinger T.G., Semus H.M., Dickinson B.A., Seto A.G., Lynch J.M., et al. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124:1537-1547.
109. Hullinger T.G., Montgomery R.L., Seto A.G., Dickinson B.A., Semus H.M., Lynch J.M., et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 2012, 110:71-81. [Epub 2011 Nov 3].